drugset / Trial / NCT00203099
Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
NaSingle-groupOpen-labelTreatment
Summary
This study evaluates the effect of the therapy combining GA and NAC on disease activity as reflected by MRI parameters while assessing tolerability and safety.
Timeline
- Start
- 2004-12
- Primary completion
- 2006-08
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glatiramer Acetate | Small molecule | 20 mg | Subcutaneous |
| Comparator | N-acetylcysteine | Small molecule | 2.5 g | Oral |